MMP-3, ESR, and CRP in the high disease activity group were significantly higher than those in the low disease activity group (p < 0.05, AUC > 0.7), indicating their potential as biomarkers in RA disease activity stratification. This evidence concerns the gene CRP and rheumatoid arthritis.